Artisan Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Artisan Partners’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-161,346	Closed	-$4.25M	–	359
2021 Q4	$4.25M	Sell	161,346 -464	-0.3%	-$35.9K	0.01%	326
2021 Q3	$16.3M	Buy	161,810 +2,932	+2%	+$344K	0.02%	295
2021 Q2	$22.5M	Buy	158,878 +49,225	+45%	+$5.56M	0.03%	290
2021 Q1	$10.9M	Buy	109,653 +2,634	+2%	+$307K	0.01%	318
2020 Q4	$13.2M	Buy	+107,019	New	+$14.1M	0.02%	308

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Artisan Partners's RETA Position: Q1 2022 in Review

Artisan Partners sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2022, closing a stake of 161,346 shares — an estimated $4.25M sold.

Artisan Partners first reported a position in RETA in Q4 2020 and held it in 5 quarters. The position peaked at $22.5M in Q2 2021. 149 funds tracked by Wall St. Rank hold RETA as of Q1 2022.

Artisan Partners reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Artisan Partners sold 161,346 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2022, an estimated $4.25M.
Artisan Partners first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2020 and held it in 5 quarters.
Artisan Partners's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $22.5M in Q2 2021.
149 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2022.

Based on Artisan Partners's 13F filing for Q1 2022, filed 13 May 2022.